Real-time enrollment status for this heart failure with reduced ejection fraction (hfref) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:29 AM UTC
| NCT Number | NCT07750873 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Reduced Ejection Fraction (HFrEF) |
| Phase | PHASE2 |
| Target Enrollment | 525 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Cardurion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07750873 is currently recruiting participants. This phase2 study for heart failure with reduced ejection fraction (hfref) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Cardurion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07750873 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07750873 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.